Physician profile
William R Wise
NPI 1912092768
$9,596.53
in general payments reported to CMS, 2019-2025
45 companies · $2,104 in 2025
The $2,104 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,075 · 2020: $249 · 2021: $974 · 2022: $1,411 · 2023: $1,566 · 2024: $2,219 · 2025: $2,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,689 · Education: $185 · Travel and Lodging: $14.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,688.76 |
| Education | $184.98 |
| Travel and Lodging | $14.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,436.37 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $1,374.68 | 2023-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $659.61 | 2024-2025 | Aquabeam System |
| Dendreon Pharmaceuticals LLC | $639.35 | 2019-2025 | Provenge |
| Antares Pharma, INC. | $631.56 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Boston Scientific Corporation | $609.94 | 2019-2025 | Moses, Lithovue, Rezum Generator |
| Janssen Biotech, INC. | $414.24 | 2019-2025 | Erleada |
| Telix Pharmaceuticals | $336.23 | 2024-2025 | Illuccix |
| Myriad Genetic Laboratories, INC. | $283.58 | 2021-2024 | Prolaris |
| Urogen Pharma, INC. | $274.97 | 2022-2025 | Jelmyto |
| Myovant Sciences INC. | $261.17 | 2021-2022 | |
| Pfizer INC. | $249.46 | 2019-2024 | |
| Coloplast Corp | $200.14 | 2021-2024 | |
| Ferring Pharmaceuticals INC. | $175.20 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $171.86 | 2022-2025 | Botox, Lupron Depot |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $163.37 | 2019-2025 | |
| Medtronic, INC. | $161.66 | 2025 | Interstim |
| Teleflex LLC | $148.27 | 2022-2025 | Solesta, Urolift |
| Accord Healthcare, INC. | $138.48 | 2023-2025 | |
| 180 Medical, INC. | $134.67 | 2021-2025 | Gentlecath Glide |
| Urovant Sciences INC | $122.54 | 2022 | |
| Endo Pharmaceuticals INC. | $122.20 | 2019-2023 | Xiaflex |
| Merck Sharp & Dohme LLC | $97.49 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Endo USA, INC. | $83.37 | 2024-2025 | Xiaflex, Aveed |
| Srs Medical Systems, INC. | $77.95 | 2019 | |
| Verity Pharmaceuticals INC. | $76.43 | 2024 | Trelstar |
| Hollister Incorporated | $54.85 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $47.11 | 2019-2022 | |
| Amgen INC. | $46.47 | 2022 | |
| Axonics, INC. | $45.46 | 2021-2024 | Axonics, Bulkamid |
| Ethicon US, LLC | $38.01 | 2023-2024 | Echelon; Endopath, Surgiflo Hemostatic Matrix, Evarrest |
| Blue Earth Diagnostics | $32.78 | 2025 | Posluma |
| Angiodynamics, INC. | $32.14 | 2024 | Nanoknife |
| Halozyme INC | $30.56 | 2023 | |
| Allergan, INC. | $29.36 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $28.78 | 2019 | |
| Photocure INC | $23.54 | 2019 | |
| Innovation Technologies INC | $23.21 | 2024 | Irrisept |
| Mission Pharmacal Company | $22.54 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $22.50 | 2025 | |
| Convatec INC. | $18.13 | 2021 | |
| Palette Life Sciences, INC. | $17.18 | 2022 | |
| Immunitybio, INC. | $17.10 | 2025 | |
| Cycle Pharmaceuticals INC | $13.95 | 2024 | Tiopronin |
| Kerecis Limited | $8.07 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.